CBLL
CeriBell, IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$688.66M
P/E Ratio
—
EPS
$-1.62
Beta
—
52W High
$24.33
52W Low
$10.85
50-Day MA
$19.04
200-Day MA
$17.33
Dividend Yield
—
Profit Margin
-63.50%
Forward P/E
—
PEG Ratio
—
About CeriBell, Inc
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in Sunnyvale, California.
Fundamentals
| Revenue (TTM) | $95.07M |
| Gross Profit (TTM) | $83.39M |
| EBITDA | $-63.70M |
| Operating Margin | -78.30% |
| Return on Equity | -37.50% |
| Return on Assets | -20.70% |
| Revenue/Share (TTM) | $2.57 |
| Book Value | $3.72 |
| Price-to-Book | 4.89 |
| Price-to-Sales (TTM) | 7.24 |
| EV/Revenue | 5.99 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 29.30% |
| Shares Outstanding | $37.94M |
| Float | $25.84M |
| % Insiders | 12.88% |
| % Institutions | 86.75% |
Historical Volatility
HV 10-Day
57.62%
HV 20-Day
48.46%
HV 30-Day
74.02%
HV 60-Day
60.67%
HV Rank
94.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($26.86 target)
1
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026